129 related articles for article (PubMed ID: 15150128)
21. Kringle 5 causes cell cycle arrest and apoptosis of endothelial cells.
Lu H; Dhanabal M; Volk R; Waterman MJ; Ramchandran R; Knebelmann B; Segal M; Sukhatme VP
Biochem Biophys Res Commun; 1999 May; 258(3):668-73. PubMed ID: 10329443
[TBL] [Abstract][Full Text] [Related]
22. The histone deacetylase inhibitor NVP-LAQ824 inhibits angiogenesis and has a greater antitumor effect in combination with the vascular endothelial growth factor receptor tyrosine kinase inhibitor PTK787/ZK222584.
Qian DZ; Wang X; Kachhap SK; Kato Y; Wei Y; Zhang L; Atadja P; Pili R
Cancer Res; 2004 Sep; 64(18):6626-34. PubMed ID: 15374977
[TBL] [Abstract][Full Text] [Related]
23. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells.
Sylvester PW; Shah S
Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643
[TBL] [Abstract][Full Text] [Related]
24. Differential caspase-9-dependent signaling pathway between tumor necrosis factor receptor- and Fas-mediated hepatocyte apoptosis in mice.
Imao M; Nagaki M; Imose M; Moriwaki H
Liver Int; 2006 Feb; 26(1):137-46. PubMed ID: 16420519
[TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo antiangiogenic activity of a novel deca-peptide derived from human tissue-type plasminogen activator kringle 2.
Su L; Xu X; Zhao H; Gu Q; Zou H
Biochem Biophys Res Commun; 2010 Jun; 396(4):1012-7. PubMed ID: 20471363
[TBL] [Abstract][Full Text] [Related]
26. The inhibitory effects of recombinant plasminogen kringle 1-3 on the neovascularization of rabbit cornea induced by angiogenin, bFGF, and VEGF.
Kim JH; Kim JC; Shin SH; Chang SI; Lee HS; Chung SI
Exp Mol Med; 1999 Dec; 31(4):203-9. PubMed ID: 10630375
[TBL] [Abstract][Full Text] [Related]
27. Canstatin acts on endothelial and tumor cells via mitochondrial damage initiated through interaction with alphavbeta3 and alphavbeta5 integrins.
Magnon C; Galaup A; Mullan B; Rouffiac V; Bouquet C; Bidart JM; Griscelli F; Opolon P; Perricaudet M
Cancer Res; 2005 May; 65(10):4353-61. PubMed ID: 15899827
[TBL] [Abstract][Full Text] [Related]
28. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE
Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523
[TBL] [Abstract][Full Text] [Related]
29. Mutant anthrax toxin B moiety (protective antigen) inhibits angiogenesis and tumor growth.
Rogers MS; Christensen KA; Birsner AE; Short SM; Wigelsworth DJ; Collier RJ; D'Amato RJ
Cancer Res; 2007 Oct; 67(20):9980-5. PubMed ID: 17942931
[TBL] [Abstract][Full Text] [Related]
30. Tumor angiogenesis promoted by ex vivo differentiated endothelial progenitor cells is effectively inhibited by an angiogenesis inhibitor, TK1-2.
Oh HK; Ha JM; O E; Lee BH; Lee SK; Shim BS; Hong YK; Joe YA
Cancer Res; 2007 May; 67(10):4851-9. PubMed ID: 17510415
[TBL] [Abstract][Full Text] [Related]
31. Effects of cloned tumstatin-related and angiogenesis-inhibitory peptides on proliferation and apoptosis of endothelial cells.
Zhang GM; Zhang YM; Fu SB; Liu XH; Fu X; Yu Y; Zhang ZY
Chin Med J (Engl); 2008 Nov; 121(22):2324-30. PubMed ID: 19080341
[TBL] [Abstract][Full Text] [Related]
32. Antiangiogenic systemic gene therapy combined with doxorubicin administration induced caspase 8 and 9-mediated apoptosis in endothelial cells and an anti-metastasis effect.
Peled M; Shaish A; Greenberger S; Katav A; Hodish I; Ben-Shushan D; Barshack I; Mendel I; Frishman L; Tal R; Bangio L; Breitbart E; Harats D
Cancer Gene Ther; 2008 Aug; 15(8):535-42. PubMed ID: 18421310
[TBL] [Abstract][Full Text] [Related]
33. Membrane type 1-matrix metalloproteinase induces endothelial cell morphogenic differentiation by a caspase-dependent mechanism.
Langlois S; Di Tomasso G; Boivin D; Roghi C; Murphy G; Gingras D; Béliveau R
Exp Cell Res; 2005 Jul; 307(2):452-64. PubMed ID: 15882863
[TBL] [Abstract][Full Text] [Related]
34. Antiangiogenic gene therapy: disruption of neovascular networks mediated by inducible caspase-9 delivered with a transcriptionally targeted adenoviral vector.
Song W; Sun Q; Dong Z; Spencer DM; Núñez G; Nör JE
Gene Ther; 2005 Feb; 12(4):320-9. PubMed ID: 15616606
[TBL] [Abstract][Full Text] [Related]
35. Full kringles of plasminogen (aa 1-566) mediate complete regression of human MDA-MB-231 breast tumor xenografted in nude mice.
Galaup A; Magnon C; Rouffiac V; Opolon P; Opolon D; Lassau N; Tursz T; Perricaudet M; Griscelli F
Gene Ther; 2005 May; 12(10):831-42. PubMed ID: 15789064
[TBL] [Abstract][Full Text] [Related]
36. Blockade of angiogenesis by small molecule antagonists to protease-activated receptor-1: association with endothelial cell growth suppression and induction of apoptosis.
Zania P; Kritikou S; Flordellis CS; Maragoudakis ME; Tsopanoglou NE
J Pharmacol Exp Ther; 2006 Jul; 318(1):246-54. PubMed ID: 16595737
[TBL] [Abstract][Full Text] [Related]
37. Antiangiogenesis and anticancer efficacy of TA138, a novel alphavbeta3 antagonist.
Mousa SA; Mohamed S; Wexler EJ; Kerr JS
Anticancer Res; 2005; 25(1A):197-206. PubMed ID: 15816539
[TBL] [Abstract][Full Text] [Related]
38. Anti-angiogenic and anti-tumor apoptotic activities of SJ-8002, a new piperazine derivative.
Yi EY; Jeong EJ; Song HS; Lee MS; Kang DW; Joo JH; Kwon HS; Lee SH; Park SK; Chung SG; Cho EH; Kim YJ
Int J Oncol; 2004 Aug; 25(2):365-72. PubMed ID: 15254733
[TBL] [Abstract][Full Text] [Related]
39. [Preparation of human recombinant kringle 1-5 and its bioactivity].
Hou WH; Chai YR; Wang TY; Wang JM; Jia YL; Xue LX
Yi Chuan; 2005 Jul; 27(4):617-22. PubMed ID: 16120589
[TBL] [Abstract][Full Text] [Related]
40. Atiprimod is an inhibitor of cancer cell proliferation and angiogenesis.
Shailubhai K; Dheer S; Picker D; Kaur G; Sausville EA; Jacob GS
J Exp Ther Oncol; 2004 Dec; 4(4):267-79. PubMed ID: 15844657
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
